Overview
Radioiodine therapy is the targeted use of radioactive iodine, most commonly iodine-131, to treat thyroid disease by exploiting the thyroid gland's selective uptake of iodine through the sodium-iodide symporter. Once concentrated in thyroid follicular cells, the isotope emits beta particles that deliver localized ionizing radiation, ablating residual thyroid tissue and destroying iodine-avid tumor cells while largely sparing surrounding structures. In differentiated Thyroid Cancer of follicular cell origin, radioiodine is administered after total or near-total thyroidectomy to ablate remnant normal thyroid tissue, treat microscopic or metastatic disease, and facilitate long-term surveillance using thyroglobulin measurement and whole-body iodine scanning. Treatment is guided by risk stratification, with administered activity tailored to disease extent, and increasingly informed by molecular characterization that predicts tumor behavior and iodine avidity. Long-term outcome data from treated cohorts demonstrate its established role in management. Because the isotope is excreted in body fluids and emits penetrating gamma radiation, radiation protection is integral to therapy, including counseling and precautions to limit household and contact exposure after ambulatory administration. Careful patient selection, dosimetric considerations, and follow-up balance therapeutic efficacy against potential effects on salivary, hematologic, and other tissues.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Outcomes of Differentiated Thyroid Cancer Patients Treated with Surgery and Radioactive Iodine at SQCCCRC
Molecular Diagnosis in Clinical Management and Diagnosis of Thyroid Cancer
In The Pursuit of The Perfect Thyroid Care
How this research is being cited
The 5 articles above have been cited 8 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Ali Abdulhasan Kadhim et al. · 2020 ·
-
Ali Abdulhasan Kadhim et al. · 2020 · Radiation Protection Dosimetry
-
K. Salman et al. · 2020 · Journal of the Egyptian National Cancer Institute
-
2020 · Journal of the Egyptian National Cancer Institute
-
2020 · Radiation Protection Dosimetry
-
K. Salman et al. · 2018 · The Egyptian Journal of Radiology and Nuclear Medicine
-
Salman et al. · 2018 ·
-
2018 · The Egyptian Journal of Radiology and Nuclear Medicine
A sample of recent works citing this journal's research on Radioiodine Therapy, linking to each citing work.